Differential expression profiles of circRNAs in cancers: Future clinical and diagnostic perspectives
Since decades ago, circular RNAs (circRNAs) have been known for their critical role in RNA maturation, RNA transportation, epigenetic regulation, gene transcription, peptide/protein translation, and interaction with proteins to modulate their activities. At present, circRNAs are being extensively studied as oncotargets in the onset and development of several malignancies and treatment resistance by modulating various signaling pathways and cellular processes such as ubiquitination, degradation, invasion, proliferation, c-Myc oncoprotein stabilization, epithelial-mesenchymal transition, autophagy, and apoptosis. In addition, circRNAs are known to be highly conserved, have a longer life span than other RNAs, and their differential expressions are implicated in solid tumors and hematological malignancies. However, their potential diagnostic and therapeutic targets are not fully elucidated. Therefore, we sought to underline the opportunities and constraints associated with using these oncotargets in cancer therapy by outlining the functional mechanisms of circRNAs and their ectopic expression in distinct malignancies. The clinical applications of circRNAs in developing progressive markers like liquid biopsy biomarkers and for treating cancers are also prospected in this paper.
Mercer TR, Dinger ME, Mattick JS, 2009, Long non-coding RNAs: Insights into functions. Nat Rev Genet, 10(3):155–159. https://doi.org/10.1038/nrg2521
Consortium EP, 2012, An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57–74.
Pelechano V, Steinmetz LM, 2013, Gene regulation by antisense transcription. Nat Rev Genet, 14(12): 880–893. https://doi.org/10.1038/nrg3594
Memczak S, Jens M, Elefsinioti A, et al., 2013, Circular RNAs are a large class of animal RNAs with regulatory potency. Nature, 495(7441): 333–338. https://doi.org/10.1038/nature11928
Conn SJ, Pillman KA, Toubia J, et al., 2015, The RNA binding protein quaking regulates formation of circRNAs. Cell, 160(6): 1125–1134. https://doi.org/10.1016/j.cell.2015.02.014
Huang C, Shan G, 2015, What happens at or after transcription: Insights into circRNA biogenesis and function. Transcription, 6(4): 61–64. https://doi.org/10.1080/21541264.2015.1071301
Chen N, Zhao G, Yan X, et al., 2018, A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1. Genome Biol, 19(1): 218. https://doi.org/10.1186/s13059-018-1594-y
Zhao X, Cai Y, Xu J, 2019, Circular RNAs: Biogenesis, mechanism, and function in human cancers. Int J Mol Sci, 20(16): 3926. https://doi.org/10.3390/ijms20163926
Khan FA, Nsengimana B, Khan NH, et al., 2022, Chimeric peptides/proteins encoded by circRNA: An update on mechanisms and functions in human cancers. Front Oncol, 12: 781270. https://doi.org/10.3389/fonc.2022.781270
Salzman J, Gawad C, Wang PL, et al., 2012, Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One, 7: e30733. https://doi.org/10.1371/journal.pone.0030733
Guo JU, Agarwal V, Guo HL, et al., 2014, Expanded identification and characterization of mammalian circular RNAs. Genome Biol, 15: 409. https://doi.org/10.1186/s13059-014-0409-z
Naeli P, Pourhanifeh MH, Karimzadeh MR, et al., 2020, Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol, 145: 102854. https://doi.org/10.1016/j.critrevonc.2019.102854
Lim TB, Lavenniah A, Foo RS, 2020, Circles in the heart and cardiovascular system. Cardiovasc Res, 116(2): 269–278. https://doi.org/10.1093/cvr/cvz227
Jeck WR, Sorrentino JA, Wang K, et al., 2013, Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA, 19(2): 141–157. https://doi.org/10.1261/rna.035667.112
Patop IL, Wüst S, Kadener S, 2019, Past, present, and future of circRNAs. EMBO J, 38: e100836. https://doi.org/10.15252/embj.2018100836
Zhong Y, Du Y, Yang X, et al., 2018, Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer, 17(1): 79. https://doi.org/10.1186/s12943-018-0827-8
Nsengimana B, Khan FA, Awan UA, et al., 2022, Pseudogenes and liquid phase separation in epigenetic expression. Front Oncol, 12: 912282. https://doi.org/10.3389/fonc.2022.912282
He R, Liu P, Xie X, et al., 2017, circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR- 34a. J Exp Clin Cancer Res, 236(1): 145. https://doi.org/10.1186/s13046-017-0614-1
Zheng Q, Bao C, Guo W, et al., 2016, Circular RNA profiling reveals an abundant circhipk3 that regulates cell growth by sponging multiple miRNAs. Nat Commun, 7: 11215. https://doi.org/10.1038/ncomms11215
Ashwal-Fluss R, Meyer M, Pamudurti NR, et al., 2014, circRNA biogenesis competes with Pre-mRNA splicing. Mol Cell, 56(1): 55–66. https://doi.org/10.1016/j.molcel.2014.08.019
Kristensen LS, Hansen TB, Venø MT, et al., 2018, Circular RNAs in cancer: Opportunities and challenges in the field. Oncogene, 37(5): 555–565. https://doi.org/10.1038/onc.2017.361
Guarnerio J, Zhang Y, Cheloni G, et al., 2019, Intragenic antagonistic roles of protein and circRNA in tumorigenesis. Cell Res, 29(8): 628–640. https://doi.org/10.1038/s41422-019-0192-1
Yang W, Du WW, Li X, et al., 2016, Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis. Oncogene, 35(30): 3919–3931. https://doi.org/10.1038/onc.2015.460
Lasda E, Parker R, 2016, Circular RNAs co-precipitate with extracellular vesicles: A possible mechanism for circRNA clearance. PLoS One, 11(2): e0148407. https://doi.org/10.1371/journal.pone.0148407
Li Y, Zheng Q, Bao C, Li S, et al., 2015, Circular RNA is enriched and stable in exosomes: A promising biomarker for cancer diagnosis. Cell Res, 25(8): 981–984. https://doi.org/10.1038/cr.2015.82
Haque S, Harries LW, 2017, Circular RNAs (circRNAs) in health and disease. Genes (Basel), 8(12): 353. https://doi.org/10.3390/genes8120353
Chen J, Li Y, Zheng Q, et al., 2017, Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett, 388: 208–219. https://doi.org/10.1016/j.canlet.2016.12.006
Hsiao KY, Lin YC, Gupta SK, et al., 2017, Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Cancer Res, 77(9): 2339–2350. https://doi.org/10.1158/0008-5472.CAN-16-1883
Huang XY, Huang ZL, Xu YH, et al., 2017, Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma. Sci Rep, 7(1): 5428. https://doi.org/10.1038/s41598-017-05432-8
Wang S, Xue X, Wang R, et al., 2018, CircZNF609 promotes breast cancer cell growth, migration, and invasion by elevating p70S6K1 via sponging miR-145-5p. Cancer Manag Res, 10: 3881–3890. https://doi.org/10.2147/CMAR.S174778
Zhang X, Yang H, Zhao L, et al., 2019, Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545. Cell Death Dis, 10(8): 616. https://doi.org/10.1038/s41419-019-1863-z
Bachmayr-Heyda A, Reiner AT, Auer K, et al., 2015, Correlation of circular RNA abundance with proliferation- -exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci Rep, 5: 8057. https://doi.org/10.1038/srep08057
Yang Z, Xie L, Han L, et al., 2017, Circular RNAs: Regulators of cancer-related signaling pathways and potential diagnostic biomarkers for human cancers. Theranostics, 7(12): 3106–3117. https://doi.org/10.7150/thno.19016
Polyak K, 2011, Heterogeneity in breast cancer. J Clin Invest, 121(10): 3786–3788. https://doi.org/10.1172/JCI60534
Liu Y, Lu C, Zhou Y, et al., 2018, Circular RNA hsa_ circ_0008039 promotes breast cancer cell proliferation and migration by regulating miR-432-5p/E2F3 axis. Biochem Biophys Res Commun, 502(3): 358–363. https://doi.org/10.1016/j.bbrc.2018.05.166
Du WW, Fang L, Yang W, et al., 2017, Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ, 24(2): 357–370. https://doi.org/10.1038/cdd.2016.133
Nair AA, Niu N, Tang X, et al., 2016, Circular RNAs and their associations with breast cancer subtypes. Oncotarget, 7(49):80967–80979. https://doi.org/10.18632/oncotarget.13134
Du WW, Yang W, Li X, et al., 2018, A circular RNA circ- DNMT1 enhances breast cancer progression by activating autophagy. Oncogene, 37(44): 5829–5842. https://doi.org/10.1038/s41388-018-0369-y
Fang L, Du WW, Lyu J, et al., 2018, Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1. Cell Death Differ, 25(12): 2195–2208. https://doi.org/10.1038/s41418-018-0115-6
Xu JZ, Shao CC, Wang XJ, et al., 2019, circTADA2As suppress breast cancer progression and metastasis via targeting miR- 203a-3p/SOCS3 axis. Cell Death Dis, 10(3): 175. https://doi.org/10.1038/s41419-019-1382-y
Yang R, Xing L, Zheng X, et al., 2019, The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer, 18(1): 4. https://doi.org/10.1186/s12943-018-0933-7
Siegel RL, Miller KD, Jemal A, 2020, Cancer statistics, 2020. CA Cancer J Clin, 70(1): 7–30. https://doi.org/10.3322/caac.21590
Ahmed I, Karedath T, Andrews SS, et al., 2016, Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma. Oncotarget, 7(24): 36366–36381. https://doi.org/10.18632/oncotarget.8917
Yang X, Mei J, Wang H, et al., 2020, The emerging roles of circular RNAs in ovarian cancer. Cancer Cell Int, 20: 265. https://doi.org/10.1186/s12935-020-01367-9
Ning L, Long B, Zhang W, et al., 2018, Circular RNA profiling reveals circEXOC6B and circN4BP2L2 as novel prognostic biomarkers in epithelial ovarian cancer. Int J Oncol, 53(6): 2637–2646. https://doi.org/10.3892/ijo.2018.4566
Chen Q, Zhang J, He Y, et al., 2018, hsa_circ_0061140 Knockdown reverses FOXM1-mediated cell growth and metastasis in ovarian cancer through miR-370 sponge activity. Mol Ther Nucleic Acids, 13: 55–63. https://doi.org/10.1016/j.omtn.2018.08.010
Teng F, Xu J, Zhang M, et al., 2019, Comprehensive circular RNA expression profiles and the tumor-suppressive function of circHIPK3 in ovarian cancer. Int J Biochem Cell Biol, 112: 8–17. https://doi.org/10.1016/j.biocel.2019.04.011
Torre LA, Bray F, Siegel RL, et al., 2015, Global cancer statistics, 2012. CA Cancer J Clin, 65(2): 87–108. https://doi.org/10.3322/caac.21262
Li F, Zhang L, Li W, Deng J, et al., 2015, Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β- catenin pathway. Oncotarget, 6(8): 6001–60013. https://doi.org/10.18632/oncotarget.3469
Li P, Chen S, Chen H, et al., 2015, Using circular RNA as a novel type of biomarker in the screening of gastric cancer. Clin Chim Acta, 444: 132–136. https://doi.org/10.1016/j.cca.2015.02.018
Chen S, Li T, Zhao Q, et al., 2017, Using circular RNA hsa_ circ_0000190 as a new biomarker in the diagnosis of gastric cancer. Clin Chim Acta, 466: 167–171. https://doi.org/10.1016/j.cca.2017.01.025
Li WH, Song YC, Zhang H, et al., 2017, Decreased expression of Hsa_circ_00001649 in gastric cancer and its clinical significance. Dis Markers, 2017: 4587698. https://doi.org/10.1155/2017/4587698
Sui W, Shi Z, Xue W, et al., 2017, Circular RNA and gene expression profiles in gastric cancer based on microarray chip technology. Oncol Rep, 37(3): 1804–1814. https://doi.org/10.3892/or.2017.5415
Huang G, Zhu H, Shi Y, et al., 2015, cir-ITCH plays an inhibitory role in colorectal cancer by regulating the Wnt/β- catenin pathway. PLoS One, 10(6): e0131225. https://doi.org/10.1371/journal.pone.0131225
Wang X, Ren Y, Ma S, et al., 2020, Circular RNA 0060745, a Novel circRNA, promotes colorectal cancer cell proliferation and metastasis through miR-4736 sponging. Onco Targets Ther, 13: 1941–1951.https://doi.org/10.2147/OTT.S240642
Zhu CL, Sha X, Wang Y, et al., 2019, Circular RNA hsa_ circ_0007142 is upregulated and targets miR-103a-2-5p in colorectal cancer. J Oncol, 2019: 9836819. https://doi.org/10.1155/2019/9836819
Zhu M, Xu Y, Chen Y, et al., 2017, Circular BANP, an upregulated circular RNA that modulates cell proliferation in colorectal cancer. Biomed Pharmacother, 88: 138–144. https://doi.org/10.1016/j.biopha.2016.12.097
Weng W, Wei Q, Toden S, et al., 2017, Circular RNA ciRS- 7-A promising prognostic biomarker and a potential therapeutic target in colorectal cancer. Clin Cancer Res, 23(14): 3918–3928. https://doi.org/10.1158/1078-0432.CCR-16-2541
Guo JN, Li J, Zhu CL, et al., 2016, Comprehensive profile of differentially expressed circular RNAs reveals that hsa_ circ_0000069 is upregulated and promotes cell proliferation, migration, and invasion in colorectal cancer. Onco Targets Ther, 9: 7451–7458. https://doi.org/10.2147/OTT.S123220
Zhang P, Zuo Z, Shang W, et al., 2017, Identification of differentially expressed circular RNAs in human colorectal cancer. Tumour Biol, 39(3): 1010428317694546. https://doi.org/10.1177/1010428317694546
Qin M, Liu G, Huo X, et al., 2016, Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma. Cancer Biomark, 16(1): 161–169. https://doi.org/10.3233/CBM-150552
Yao Z, Luo J, Hu K, et al., 2017, ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways. Mol Oncol, 11(4): 422–437. https://doi.org/10.1002/1878-0261.12045
Wang L, Long H, Zheng Q, et al., 2019, Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Mol Cancer, 18(1): 119. https://doi.org/10.1186/s12943-019-1046-7
Yang J, Li Y, Yu Z, et al., 2020, Circular RNA Circ100084 functions as sponge of miR23a5p to regulate IGF2 expression in hepatocellular carcinoma. Mol Med Rep, 21(6): 2395–2404. https://doi.org/10.3892/mmr.2020.11069
Sun XH, Wang YT, Li GF, et al., 2020, Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma. Cancer Cell Int, 20: 226. https://doi.org/10.1186/s12935-020-01302-y
Rybak-Wolf A, Stottmeister C, Glažar P, et al., 2015, Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell, 58(5): 870–885. https://doi.org/10.1016/j.molcel.2015.03.027
Song X, Zhang N, Han P, et al., 2016, Circular RNA profile in gliomas revealed by identification tool UROBORUS. Nucleic Acids Res, 44(9): e87. https://doi.org/10.1093/nar/gkw075
Ng P, Qiu Z, Jiang Y, et al., 2016, Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/β-catenin signaling pathway. Oncotarget, 7(39): 63449–63455. https://doi.org/10.18632/oncotarget.11523
Zhu J, Ye J, Zhang L, et al., 2017, Differential expression of circular RNAs in glioblastoma multiforme and its correlation with prognosis. Transl Oncol, 10(2): 271–279. https://doi.org/10.1016/j.tranon.2016.12.006
Zheng J, Liu X, Xue Y, et al., 2017, TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/ HNF1β/Derlin-1 pathway. J Hematol Oncol, 10(1): 52. https://doi.org/10.1186/s13045-017-0422-2
Chen Z, Duan X, 2018, Hsa_circ_0000177-miR-638- FZD7-Wnt signaling cascade contributes to the malignant behaviors in glioma. DNA Cell Biol, 37(9): 791–797. https://doi.org/10.1089/dna.2018.4294
Wang R, Zhang S, Chen X, et al., 2020, EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis. Mol Cancer, 17(1): 166. https://doi.org/10.1186/s12943-018-0911-0
Liu Y, Ma C, Qin X, et al., 2019, Circular RNA circ_001350 regulates glioma cell proliferation, apoptosis, and metastatic properties by acting as a miRNA sponge. J Cell Biochem, 120(9): 15280–15287. https://doi.org/10.1002/jcb.28795
He J, Huang Z, He M, et al., 2020, Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas. Mol Cancer, 19(1): 17. https://doi.org/10.1186/s12943-019-1120-1
Wang J, Zhao L, Shang K, et al., 2020. Long non-coding RNA H19, a novel therapeutic target for pancreatic cancer. Mol Med, 26(1): 30. https://doi.org/10.1186/s10020-020-00156-4
Li H, Hao X, Wang H, et al., 2016, Circular RNA expression profile of pancreatic ductal adenocarcinoma revealed by microarray. Cell Physiol Biochem, 40(6): 1334–1344. https://doi.org/10.1159/000453186
Yang J, Cong X, Ren M, et al., 2019, Circular RNA hsa_ circRNA_0007334 is predicted to promote MMP7 and COL1A1 expression by functioning as a miRNA sponge in pancreatic ductal adenocarcinoma. J Oncol, 2019: 7630894. https://doi.org/10.1155/2019/7630894
Yao J, Zhang C, Chen Y, et al., 2019, Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. Life Sci, 239: 116871. https://doi.org/10.1016/j.lfs.2019.116871
Chen YY, Jiang MJ, Tian L, 2020, Analysis of exosomal circRNAs upon irradiation in pancreatic cancer cell repopulation. BMC Med Genomics, 13(1): 107. https://doi.org/10.1186/s12920-020-00756-3
Guo X, Zhou Q, Su D, et al., 2020, Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. Mol Cancer, 19(1): 83. https://doi.org/10.1186/s12943-020-01196-4
Wong CH, Lou UK, Li Y, et al., 2020, CircFOXK2 promotes growth and metastasis of pancreatic ductal adenocarcinoma by complexing with RNA-binding proteins and sponging MiR-942. Cancer Res, 80(11): 2138–2149. https://doi.org/10.1158/0008-5472.CAN-19-3268
Zhang X, Yang D, Wei Y, 2018, Overexpressed CDR1as functions as an oncogene to promote the tumor progression via miR-7 in non-small-cell lung cancer. Onco Targets Ther, 11: 3979–3987. https://doi.org/10.2147/OTT.S158316
Wang X, Zhu X, Zhang H, et al., 2018, Increased circular RNA hsa_circ_0012673 acts as a sponge of miR-22 to promote lung adenocarcinoma proliferation. Biochem Biophys Res Commun, 496(4): 1069–1075. https://doi.org/10.1016/j.bbrc.2018.01.126
Qu D, Yan B, Xin R, et al., 2018, A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer. Am J Cancer Res, 8(8): 1387–1402.
Xue YB, Ding MQ, Xue L, et al., 2019, CircAGFG1 sponges miR-203 to promote EMT and metastasis of non-small-cell lung cancer by upregulating ZNF281 expression. Thorac Cancer, 10(8): 1692–1701. https://doi.org/10.1111/1759-7714.13131
Shangguan H, Feng H, Lv D, et al., 2020, Circular RNA circSLC25A16 contributes to the glycolysis of non-small-cell lung cancer through epigenetic modification. Cell Death Dis, 11(6): 437. https://doi.org/10.1038/s41419-020-2635-5
Chen L, Nan A, Zhang N, et al., 2019, Circular RNA 100146 functions as an oncogene through direct binding to miR- 361-3p and miR-615-5p in non-small cell lung cancer. Mol Cancer, 18(1): 13. https://doi.org/10.1186/s12943-019-0943-0
Li X, Zhang Z, Jiang H, et al., 2018, Circular RNA circPVT1 promotes proliferation and invasion through sponging miR- 125b and activating E2F2 signaling in non-small cell lung cancer. Cell Physiol Biochem, 51(5): 2324–2340. https://doi.org/10.1159/000495876
Qin S, Zhao Y, Lim G, et al., 2019, Circular RNA PVT1 acts as a competing endogenous RNA for miR-497 in promoting non-small cell lung cancer progression. Biomed Pharmacother, 111: 244–250. https://doi.org/10.1016/j.biopha.2018.12.007
Zong L, Sun Q, Zhang H, et al., 2018, Increased expression of circRNA_102231 in lung cancer and its clinical significance. Biomed Pharmacother, 102: 639–644. https://doi.org/10.1016/j.biopha.2018.03.084
Hang D, Zhou J, Qin N, et al., 2018, A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer. Cancer Med, 7(6): 2783–2791. https://doi.org/10.1002/cam4.1514
Huang EY, Chang YJ, Huang SP, et al., 2018, A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer. J Cell Mol Med, 22(7): 3661–3670. https://doi.org/10.1111/jcmm.13649
Xia Q, Ding T, Zhang G, et al., 2018, Circular RNA expression profiling identifies prostate cancer-specific circRNAs in prostate cancer. Cell Physiol Biochem, 50(5): 1903–1915. https://doi.org/10.1159/000494870
Greene J, Baird AM, Casey O, et al., 2019, Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide. Sci Rep, 9(1): 10739. https://doi.org/10.1038/s41598-019-47189-2
Kong Z, Wan X, Lu Y, et al., 2020, Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR-29a-3p. J Cell Mol Med, 24(1): 799–813. https://doi.org/10.1111/jcmm.14791
Wu YP, Lin XD, Chen SH, et al., 2020, Identification of prostate cancer-related circular RNA through bioinformatics analysis. Front Genet, 11: 892. https://doi.org/10.3389/fgene.2020.00892
Ge S, Sun C, Hu Q, et al., 2020, Differential expression profiles of circRNAs in human prostate cancer based on chip and bioinformatic analysis. Int J Clin Exp Pathol, 13(5): 1045–1052.
Cai C, Zhi Y, Wang K, et al., 2019, CircHIPK3 overexpression accelerates the proliferation and invasion of prostate cancer cells through regulating miRNA-338-3p. Onco Targets Ther, 12: 3363–3372. https://doi.org/10.2147/OTT.S196931
Wang X, Wang R, Wu Z, et al., 2019, Circular RNA ITCH suppressed prostate cancer progression by increasing HOXB13 expression via spongy miR-17-5p. Cancer Cell Int, 19: 328. https://doi.org/10.1186/s12935-019-0994-8
Szymczyk A, Macheta A, Podhorecka M, 2018, Abnormal microRNA expression in the course of hematological malignancies. Cancer Manag Res, 10: 4267–4277. https://doi.org/10.2147/CMAR.S174476
Li W, Zhong C, Jiao J, et al., 2017, Characterization of hsa_ circ_0004277 as a new biomarker for acute myeloid leukemia via circular RNA profile and bioinformatics analysis. Int J Mol Sci, 18(3): 597. https://doi.org/10.3390/ijms18030597
L’Abbate A, Tolomeo D, Cifola I, et al., 2018, MYC-containing amplicons in acute myeloid leukemia: Genomic structures, evolution, and transcriptional consequences. Leukemia, 32(10): 2152–2166. https://doi.org/10.1038/s41375-018-0033-0
Liu J, Kong F, Lou S, et al., 2018, Global identification of circular RNAs in chronic myeloid leukemia reveals hsa_ circ_0080145 regulates cell proliferation by sponging miR- 29b. Biochem Biophys Res Commun, 504(4): 660–665. https://doi.org/10.1016/j.bbrc.2018.08.154
Xia L, Wu L, Bao J, et al., 2018, Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/ Wnt/β-catenin pathway. Biochem Biophys Res Commun, 503(1): 385–390. https://doi.org/10.1016/j.bbrc.2018.06.045
Dahl M, Daugaard I, Andersen MS, et al., 2018, Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies. Lab Invest, 98(12): 1657–1669. https://doi.org/10.1038/s41374-018-0108-6
Mei M, Wang Y, Li Z, et al., 2019, Role of circular RNA in hematological malignancies. Oncol Lett, 18(5): 4385–4392. https://doi.org/10.3892/ol.2019.10836
Zhong Z, Lv M, Chen J, 2016, Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in bladder carcinoma. Sci Rep, 6: 30919. https://doi.org/10.1038/srep30919
Li P, Liu H, Wang Z, et al., 2016, MicroRNAs in laryngeal cancer: Implications for diagnosis, prognosis and therapy. Am J Transl Res, 8(5): 1935–1944.
Zhang H, Wang G, Ding C, et al., 2017, Increased circular RNA UBAP2 acts as a sponge of miR-143 to promote osteosarcoma progression. Oncotarget, 8(37): 61687–61697. https://doi.org/10.18632/oncotarget.18671
Xiong Y, Zhang J, Song C, 2018, CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma. J Cell Physiol, 234(7): 10646–10654. https://doi.org/10.1002/jcp.27744
Chen L, Zhang S, Wu J, et al., 2019, circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene, 36(32): 4551–4561. https://doi.org/10.1038/onc.2017.89
De Rubis G, Krishnan SR, Bebawy M, 2019, Liquid biopsies in cancer diagnosis, monitoring, and prognosis. Trends Pharmacol Sci, 40(3): 172–186. https://doi.org/10.1016/j.tips.2019.01.006
Kwapisz D, 2017, The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer? Ann Transl Med, 5(3): 46. https://doi.org/10.21037/atm.2017.01.32
Zaporozhchenko IA, Ponomaryova AA, Rykova EY, et al., 2018, The potential of circulating cell-free RNA as a cancer biomarker: Challenges and opportunities. Expert Rev Mol Diagn, 18(2): 133–145. https://doi.org/10.1080/14737159.2018.1425143
Lamb YN, Dhillon S, (2017), Epi proColon® 2.0 CE: A blood-based screening test for colorectal cancer. Mol Diagn Ther, 21(2): 225–232. https://doi.org/10.1007/s40291-017-0259-y
Baassiri A, Nassar F, Mukherji D, et al., 2020, Exosomal non coding RNA in LIQUID biopsies as a promising biomarker for colorectal cancer. Int J Mol Sci, 21(4): 1398. https://doi.org/10.3390/ijms21041398
He AT, Liu J, Li F, et al., 2021, Targeting circular RNAs as a therapeutic approach: Current strategies and challenges. Signal Transduct Target Ther, 6(1): 185. https://doi.org/10.1038/s41392-021-00569-5
Wen G, Zhou T, Gu W, 2020, The potential of using blood circular RNA as liquid biopsy biomarker for human diseases. Protein Cell, 12(12): 911–946. https://doi.org/10.1007/s13238-020-00799-3
Nsengimana B, Khan FA, Ngowi EE, et al., 2022, Processing body (P-body) and its mediators in cancer. Mol Cell Biochem, 477(4): 1217–1238. https://doi.org/10.1007/s11010-022-04359-7
Lampis, A. Ghidini, M. Ratti, et al., 2020, Circulating tumour DNAs and non-coding RNAs as liquid biopsies for the management of colorectal cancer patients. Gastrointest Disord, 2: 212–235. https://doi.org/10.3390/gidisord2030022
Zhang Z, Yang T, Xiao J, 2018, Circular RNAs: Promising biomarkers for human diseases. EBioMedicine, 34: 267–274. https://doi.org/10.1016/j.ebiom.2018.07.036
Li Y, Li C, Xu R, et al., 2019, A novel circFMN2 promotes tumor proliferation in CRC by regulating the miR- 1182/hTERT signaling pathways. Clin Sci (Lond), 133(24): 2463–2479. https://doi.org/10.1042/CS20190715
Feng W, Gong H, Wang Y, et al., 2019, circIFT80 Functions as a ceRNA of miR-1236-3p to promote colorectal cancer progression. Mol Ther Nucleic Acids, 18: 375–387. https://doi.org/10.1016/j.omtn.2019.08.024
Yin WB, Yan MG, Fang X, et al., 2018, Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detection. Clin Chim Acta, 487: 363–368. https://doi.org/10.1016/j.cca.2017.10.011
Yang C, Wei Y, Yu L, et al., 2019, Identification of altered circular RNA expression in serum exosomes from patients with papillary thyroid carcinoma by high-throughput sequencing. Med Sci Monit, 25: 2785–2791. https://doi.org/10.12659/MSM.915658
Fan CM, Wang JP, Tang YY, et al., 2019, circMAN1A2 could serve as a novel serum biomarker for malignant tumors. Cancer Sci, 110(7): 2180–2188. https://doi.org/10.1111/cas.14034
Wang X, Yao Y, Jin M, 2020, Circ-0001068 is a novel biomarker for ovarian cancer and inducer of PD1 expression in T cells. Aging (Albany NY), 12(19):19095-19106. https://doi.org/10.18632/aging.103706
Xu H, Gong Z, Shen Y, et al., 2018, Circular RNA expression in extracellular vesicles isolated from serum of patients with endometrial cancer. Epigenomics, 10(2): 187–197. https://doi.org/10.2217/epi-2017-0109
Ji W, Qiu C, Wang M, et al., 2018, Hsa_circ_0001649: A circular RNA and potential novel biomarker for colorectal cancer. Biochem Biophys Res Commun, 497(1): 122–126. https://doi.org/10.1016/j.bbrc.2018.02.036
Li XN, Wang ZJ, Ye CX, et al., 2019, Circular RNA circVAPA is upregulated and exerts oncogenic properties by sponging miR-101 in colorectal cancer. Biomed Pharmacother, 112: 108611. https://doi.org/10.1016/j.biopha.2019.108611
Li J, Song Y, Wang J, et al., 2020, Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer detection. Am J Transl Res, 12(11): 7395–7403.
Pan B, Qin J, Liu X, et al., 2019, Identification of serum exosomal hsa-circ-0004771 as a novel diagnostic biomarker of colorectal cancer. Front Genet, 10: 1096. https://doi.org/10.3389/fgene.2019.01096
Huang M, He YR, Liang LC, et al., 2017, Circular RNA hsa_ circ_0000745 may serve as a diagnostic marker for gastric cancer. World J Gastroenterol, 23(34): 6330–6338. https://doi.org/10.3748/wjg.v23.i34.6330
Li T, Shao Y, Fu L, et al., 2018, Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection. J Mol Med (Berl), 96(1): 85–96. https://doi.org/10.1007/s00109-017-1600-y
Sun H, Tang W, Rong D, et al., 2018, Hsa_circ_0000520, a potential new circular RNA biomarker, is involved in gastric carcinoma. Cancer Biomark, 21(2): 299–306. https://doi.org/10.3233/CBM-170379
Lu J, Zhang PY, Xie JW, et al., 2019, Hsa_circ_0000467 promotes cancer progression and serves as a diagnostic and prognostic biomarker for gastric cancer. J Clin Lab Anal, 33(3): e22726. https://doi.org/10.1002/jcla.22726
Chen X, Chen RX, Wei WS, et al., 2018, PRMT5 circular RNA promotes metastasis of urothelial carcinoma of the bladder through sponging miR-30c to induce epithelial-mesenchymal transition. Clin Cancer Res, 24(24): 6319–6330. https://doi.org/10.1158/1078-0432.CCR-18-1270
Shuai M, Hong J, Huang D, et al., 2018, Upregulation of circRNA_0000285 serves as a prognostic biomarker for nasopharyngeal carcinoma and is involved in radiosensitivity. Oncol Lett, 16(5): 6495–6501. https://doi.org/10.3892/ol.2018.9471
Hu J, Han Q, Gu Y, et al., 2018, Circular RNA PVT1 expression and its roles in acute lymphoblastic leukemia. Epigenomics, 10(6): 723–732. https://doi.org/10.2217/epi-2017-0142
Wu Z, Sun H, Wang C, et al., 2020, Mitochondrial genome-derived circRNA mc-COX2 functions as an oncogene in chronic lymphocytic leukemia. Mol Ther Nucleic Acids, 20: 801–811. https://doi.org/10.1016/j.omtn.2020.04.017
Luo Y, Gui R, 2020, Circulating exosomal CircMYC is associated with recurrence and bortezomib resistance in patients with multiple myeloma. Turk J Haematol, 37(4): 248–262. https://doi.org/10.4274/tjh.galenos.2020.2020.0243
Wang Y, Lin Q, Song C, et al., 2020, Circ_0007841 promotes the progression of multiple myeloma through targeting miR- 338-3p/BRD4 signaling cascade. Cancer Cell Int, 20: 383. https://doi.org/10.1186/s12935-020-01475-6
Li Z, Zhou Y, Yang G, et al., 2019, Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma. Clin Chim Acta, 492: 37–44. https://doi.org/10.1016/j.cca.2019.02.001
Zhang H, Deng T, Ge S, et al., 2019, Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7. Oncogene, 38(15): 2844–2859. https://doi.org/10.1038/s41388-018-0619-z
Zhang PF, Gao C, Huang XY, et al., 2020, Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma. Mol Cancer, 19(1): 110. https://doi.org/10.1186/s12943-020-01222-5
Yang F, Liu DY, Guo JT, et al., 2017, Circular RNA circ- LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. World J Gastroenterol, 23(47): 8345–8354. https://doi.org/10.3748/wjg.v23.i47.8345
Zhao SY, Wang J, Ouyang SB, et al., 2018, Salivary circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as novel biomarkers for the diagnosis of oral squamous cell carcinoma. Cell Physiol Biochem, 47(6): 2511–2521. https://doi.org/10.1159/000491624
Zhu K, Niu L, Wang J, et al., 2019, Circular RNA hsa_ circ_0000885 levels are increased in tissue and serum samples from patients with osteosarcoma. Med Sci Monit, 25: 1499–1505. https://doi.org/10.12659/MSM.914899
Zhu X, Wang X, Wei S, et al., 2017, Hsa_circ_0013958: A circular RNA and potential novel biomarker for lung adenocarcinoma. FEBS J, 284(14): 2170–2182. https://doi.org/10.1111/febs.14132
Ayers D, Vandesompele J, 2017, Influence of microRNAs and long non-coding RNAs in cancer chemoresistance. Genes (Basel), 8(3): 95. https://doi.org/10.3390/genes8030095
Ding C, Yi X, Wu X, et al., 2020, Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma. Cancer Lett, 479: 1–12. https://doi.org/10.1016/j.canlet.2020.03.002
Shao F, Huang M, Meng F, et al., 2018, Circular RNA signature predicts gemcitabine resistance of pancreatic ductal adenocarcinoma. Front Pharmacol, 9: 584. https://doi.org/10.3389/fphar.2018.00584
Xia X, Li X, Li F, et al., 2019, A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1. Mol Cancer, 18(1): 131. https://doi.org/10.1186/s12943-019-1056-5
Kartal-Yandim M, Adan-Gokbulut A, Baran Y, 2016, Molecular mechanisms of drug resistance and its reversal in cancer. Crit Rev Biotechnol, 36(4): 716–726. https://doi.org/10.3109/07388551.2015.1015957
Zhou R, Wu Y, Wang W, et al., 2018, Circular RNAs (circRNAs) in cancer. Cancer Lett, 425: 134–142. https://doi.org/10.1016/j.canlet.2018.03.035
Papatsirou M, Artemaki PI, Scorilas A, et al., 2020, The role of circular RNAs in therapy resistance of patients with solid tumors. Per Med, 17(6): 469–490. https://doi.org/10.2217/pme-2020-0103
Kun-Peng Z, Xiao-Long M, Chun-Lin Z, 2018, Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1. Int J Biol Sci, 14(3): 321–330. https://doi.org/10.7150/ijbs.24360
Sang Y, Chen B, Song X, et al., 2019, Circrna_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer. Mol Ther, 27(9): 1638–1652. https://doi.org/10.1016/j.ymthe.2019.05.011
Komseli ES, Pateras IS, Krejsgaard T, et al., 2018, A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence. BMC Genomics, 19(1): 37. https://doi.org/10.1186/s12864-017-4375-1
Gokool A, Anwar F, Voineagu I, 2020, The landscape of circular RNA expression in the human brain. Biol Psychiatry, 87(3): 294–304. https://doi.org/10.1016/j.biopsych.2019.07.029
Sachs N, Papaspyropoulos A, Ommen DD, et al., 2019, Long-term expanding human airway organoids for disease modeling. EMBO J, 38(4): e100300. https://doi.org/10.15252/embj.2018100300
Wiener DJ, Basak O, Asra P, et al., 2018, Establishment and characterization of a canine keratinocyte organoid culture system. Vet Dermatol, 29(5): 375–e126. https://doi.org/10.1111/vde.12541
Cao J, Zhang X, Xu P, et al., 2021, Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer progression via the WNT2/β-catenin pathway. J Exp lin Cancer Res, 40(1): 6. https://doi.org/10.1186/s13046-020-01791-9
Zhang X, Wang S, Wang H, et al., 2019, Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer, 18(1): 20. https://doi.org/10.1186/s12943-018-0935-5
Piwecka M, Glažar P, Hernandez-Miranda LR, et al., 2017, Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science, 357(6357): eaam8526. https://doi.org/10.1126/science.aam8526
Pamudurti NR, Patop IL, Krishnamoorthy A, et al., 2020, An in vivo strategy for knockdown of circular RNAs. Cell Discov, 6: 52. https://doi.org/10.1038/s41421-020-0182-y
Costa MC, Calderon-Dominguez M, Mangas A, et al., 2021, Circulating circRNA as biomarkers for dilated cardiomyopathy etiology. J Mol Med (Berl), 99(12): 1711–1725. https://doi.org/10.1007/s00109-021-02119-6